J&J | سود ناخالص در فروش



Gross Profit On Sales تغییر دادن تاریخ
AbbVie USD 10.71B 458M 2024-12
Abbott USD 5.92B 114M 2025-03
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Baxter International USD 1.02B 19M 2024-12
Bayer EUR 8.11B 2.11B 2025-03
Becton, Dickinson and Co. USD 2.26B 22M 2025-03
Biogen USD 1.87B 44.1M 2024-12
Boston Scientific USD 3.2B 97M 2025-03
Bristol-Myers Squibb USD 8.18B 947M 2025-03
CONMED USD 181.16M 17.18M 2025-03
Cooper Companies USD 660.2M 17.5M 2025-01
Dexcom USD 589M 120.3M 2025-03
Edwards Lifesciences USD 1.11B 17.5M 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
Globus Medical USD 402.72M 8.87M 2025-03
Hologic USD 560.7M 19.8M 2025-03
Indivior 222M 54M 2025-03
Insulet USD 409M 21.9M 2025-03
Integra LifeSciences USD 215.14M 50.7M 2025-03
Intuitive Surgical USD 1.46B 184.5M 2025-03
J&J USD 14.6B 816M 2025-03
Medtronic USD 5.81B 296M 2025-04
Merck USD 12.77B 849M 2025-03
Merit Medical Systems USD 172.02M 963K 2025-03
Novartis USD 10.23B 294M 2024-12
Pfizer USD 11.12B 987M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
Stryker USD 3.81B 385M 2025-03
Tandem Diabetes Care USD 118.41M 39.05M 2025-03
Teva Pharmaceutical Industries USD 1.91B 206M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12
Zoetis USD 1.6B 12M 2025-03



J&J سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - May 2025.